FdaApplication
NDA 205613
Identifiers
- fda_app_no: NDA205613
Properties
| Property | Value |
|---|---|
| applicant_name | SALIX PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2014-10-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| UCERIS | BUDESONIDE | 2MG/ACTUATION | AEROSOL, FOAM;RECTAL |
1 product